| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.5M | +2952.4% |
| Cost of Revenue | $17.3M | +3895.1% |
| Gross Profit | $2.2M | +975.2% |
| R&D Expense | $14.1M | +310.5% |
| SG&A Expense | $82.7M | +99.2% |
| Operating Income | -$94.5M | -111.4% |
| Income Tax | $0 | — |
| Net Income | -$111.1M | -98.0% |
| EPS (Basic) | -$1.27 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -85.9% |
| Accounts Receivable | $2.7M | +2346.4% |
| Inventory | $3.6M | +289.8% |
| Current Assets | $34.1M | -67.7% |
| Total Assets | $278.7M | +93.7% |
| Current Liabilities | $23.3M | +29.5% |
| Long-term Debt | $119.8M | +969.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.8M | -142.7% |
| Capital Expenditures | $56.0M | +88.8% |
| Investing Cash Flow | -$172.4M | -481.1% |
| Financing Cash Flow | $145.1M | -3.8% |
| Free Cash Flow | -$104.8M | -110.6% |
| -19.8% |
| EPS (Diluted) | -$1.27 | -19.8% |
| Total Liabilities |
| $157.4M |
| +272.6% |
| Stockholders' Equity | $121.3M | +19.3% |